EDAP Announces Participation in Healthcare Conference
EDAP TMS SA, a prominent player in the realm of robotic energy-based therapies, is gearing up for significant engagements at the upcoming UBS Global Healthcare Conference. This event provides an ideal platform for industry leaders and investors to connect and explore innovative medical solutions.
Details of the Upcoming Conference
The conference will be held from November 10 through November 13, and will take place at the PGA National Resort Hotel, where EDAP will host 1x1 investor meetings. This is a prime opportunity for investors and stakeholders to meet with key executives from EDAP.
Who Will Attend?
Ryan Rhodes, the Chief Executive Officer of EDAP, along with Ken Mobeck, the Chief Financial Officer, are slated to represent the company at these meetings. Their presence signifies the importance of investor relations in advancing EDAP's mission to deliver groundbreaking therapies.
Registration Information
Interested parties are encouraged to register for this exclusive opportunity. Registration is open specifically for UBS clients, and they can also get in touch with their UBS sales representative for more information.
About EDAP TMS SA
EDAP TMS SA is at the forefront of developing, manufacturing, and distributing innovative medical devices that utilize ultrasound technology for minimally invasive procedures. They are especially noted for their leadership in robotic energy-based therapy, particularly with the Focal One system. This advanced technology is acclaimed for its precision and effectiveness in prostate focal therapy, managed by urologists, with promising avenues for treatment extensions beyond just prostate cancer.
Innovative Solutions and Future Directions
With a firm commitment to advancing medical technology, EDAP continues to explore new fronts in non-invasive treatments. Their cutting-edge developments in imaging and robotics are set to revolutionize how various conditions are managed, paving the way for enhanced patient outcomes.
Company Contacts
For further inquiries, Blandine Confort leads the Investor Relations and Legal Affairs department at EDAP TMS. Investors or interested parties seeking more information on the company can reach out via the provided contact details.
Investor Relations
John Fraunces is available through LifeSci Advisors for investor-related questions. Their proactive outreach exemplifies EDAP's dedication to transparency and communication with their stakeholders.
Frequently Asked Questions
What is the UBS Global Healthcare Conference?
The UBS Global Healthcare Conference is a prominent event where healthcare companies meet and engage with investors and other stakeholders to discuss innovations and growth strategies.
Who are the key representatives of EDAP at the conference?
Ryan Rhodes and Ken Mobeck will represent EDAP, engaging directly with investors during one-on-one meetings.
What is the significance of EDAP's technologies?
EDAP's technologies are designed for minimally invasive medical treatments, significantly enhancing patient care and recovery times through advanced ultrasound solutions.
How can investors participate in the conference?
Investors can participate by registering through UBS, as the conference is specifically tailored for UBS clients.
What innovations is EDAP focused on?
EDAP is primarily focused on robotic energy-based therapies and expanding the applications of their technologies beyond prostate treatments to other potential medical conditions.
